You are here: Industry Insights > Brand Story > Zhejiang Esigma Biotechnology Co.,Ltd --Virtual Factory Tours

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Zhejiang Esigma Biotechnology Co.,Ltd --Virtual Factory Tours

June 10, 2020

Tag: Virtual Factory Tours , VEC , CPHI China

Favorites

Company Profile:

Zhejiang Esigma Biotechnology Co., Ltd. is a high-tech enterprise which produces and sells feedstuff pharmaceutical additives (including API and premix) by continuous innovation and research. Our core business improves animal health and growth performance by improving feed efficiency, through innovative use of fine chemical, bio-fermentation and animal growth promoter.

Nosiheptide -First developed & marked in China;

Robenidine HCL-First got GMP approval in China & NO.1 sales in the World;Nicarbazine ----Biggest GMP Manufacturer in China

Main Products:

Tributyrin(60-01-5)

For more information, click here to view my store.

Previous:Zhejiang Esigma Biotechnology Co.,Ltd -Virtual Factory Tours

Next:New consortium EUbOPEN will provide tools to unlock disease biology

What companies are developing CNS drugs in China?

ChatGTP/PharmaSourcesNovember 08, 2023

Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

PharmaSourcesMay 15, 2023

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

PharmaSources.comMay 27, 2022

Zhejiang Esigma Biotechnology Co.,Ltd --Virtual Factory Tours | Pharmasources.com

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

PharmaSources.comDecember 30, 2021

Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.

Zhejiang Esigma Biotechnology Co.,Ltd --Virtual Factory Tours

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may like
More>>

Zhejiang Esigma Biotechnology Co.,Ltd --Virtual Factory Tours

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may likeMore>>

You may like
More>>